Welcome Back to the MenWithFibro Forums
It does not matter the name, We all have the same symptoms.

Main Menu

ShoutBox! For quick short shout outs to other members. For introductions, questions or comments please post in the proper sections of the forum.

2023 Nov 18 19:10:11
ronr: Sorry folks but we have to move again.  Finances is the major reason and but the new hosting service is kicking back tons of errors and things just aren't work well!  I cleaned out the shoutbox just so that the changes messages will stand out better!

2023 Nov 18 19:06:32
ronr: Facebook does not allow nearly the amount of privacy and they search for people and groups thatdon't follow their guidelines.

2023 Nov 13 19:25:44
ronr: This link is an invitation for those that would like to follow us!

2023 Nov 13 19:25:04
ronr: Discord is new to most of us but there is a GREAT DEAL of privacy there.  You need to be invited to even see our page.  Download of the app is easy and there are plenty of directions

Darvon Blog

Started by ronr, February 03, 2009, 09:53:54 AM

Previous topic - Next topic

0 Members and 20 Guests are viewing this topic.


Darvon Worthless? 
By: Dr. Wes  |  February 02, 2009 
I was at a social gathering Friday and met an experienced nurse from a local bone marrow transplant unit. She mentioned to me that an FDA panel met to decided to recommend that Darvon (propoxyphene) be banned from the US market.

"Man, we use Darvon a lot," she said. "It's one of the few drugs we give for our patients that doesn't mask fever. Everyone in our unit gets Darvon. If we suppressed fever, we'd be much slower at recognizing infection in our unit."

The FDA panel made its decision based on some interesting testimony from Sidney Wolfe, M.D. from Public Citizen. His data were based largely on the Drug Abuse Warning Network (DAWN) that collects data from emergency rooms and medical examiners concerning drugs that have been determined to be related to emergency room visits or deaths. In that testimony, he claimed that 503 deaths were "related" to propoxyphene even though the data "do not imply causality but rather that the death was related to the drug." Note that only 25 of those deaths were classified as single drug. I wonder, was propoxyphene the causal agent in the other deaths? How many of these deaths was the drug actually prescribed to the deceased? Should death from suicide be classified the same as death from accidental poisoning?

Aron J. Hall, D.V.M., M.S.P.H., of the Centers for Disease Control and Prevention, in Atlanta, and colleagues conducted a study to determine the risk characteristics and other factors associated with persons dying of unintentional pharmaceutical overdose in West Virginia in 2006. In their study, opioid analgesics were the most prevalent class of drugs, contributing to 93.2 percent of deaths; of these, only 44.4 percent included evidence of prescription documentation for all of the contributory opioids.

Now, compare this to the deaths from acetominophen (Tylenol) -- more than 56,000 emergency room visits and an estimated 458 deaths from acute liver failure in 2003. Should such similar data lead to acetominophen's removal from the U.S. market, too?

Used properly, statistics can be powerful allies in supporting arguments during public policy decisions. But when those numbers are not couched beside their limitations or other confounding factors, they can misrepresent as well.

The implications of stopping a drug that has been available in the American medical pharmacopoeia for over 50 years should be carefully scrutinized. I can recall when isoproterenol (Isuprel) was discontinued due to the lack of a market - even though its purely chronotropic (heart rate increasing) cardiac effects were vital to our electrophysiology studies. We quickly learned that our EP studies were markedly adversely affected. Fortunately, after significant outcry from our profession, the drug was reinstated.

As the nurse I met made apparent, some old drugs like Darvon may still have niche areas with distinct advantages and cost savings. These niche areas should be appreciated and recognized before wholesale withdrawal of any drug is mandated. Putting shoddy statistics in perspective might help assure proper public policy decisions are reached.

Times are tough when "Happy Hour" is your nap.
My mind not only wanders, sometimes it leaves completely!

SMF spam blocked by CleanTalk